In Sierra Leone, the female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 stands at 24.7%, reflecting an increase of 0.6% (2.5%) compared to 2020.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Sierra Leone
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2021
Points:
13,975
Measure:
%
More indicators for Sierra Leone
Out-of-pocket expenditure PPP per capita
intl dollar84
+intl dollar3
(2022)
Newborns protected against tetanus
90%
-3%
(2023)
Female wasting in children
5.7%
+0.5%
(2021)
Birth registration
90.4%
+9.3%
(2019)
Female prevalence of HIV
1%
-0.1%
(2022)
Contraceptive modern method prevalence
20.9%
-1%
(2019)
Sierra Leone Female CVD, cancer, diabetes or CRD between 2000 and 2021
Period | Value | Change |
---|---|---|
2021 | 24.7% | +0.6% |
2020 | 24.1% | -0.8% |
2019 | 24.9% | -0.2% |
2018 | 25.1% | -0.2% |
2017 | 25.3% | 0% |
2016 | 25.3% | +0.4% |
2015 | 24.9% | 0% |
2014 | 24.9% | -0.7% |
2013 | 25.6% | -0.8% |
2012 | 26.4% | -0.3% |
2011 | 26.7% | -0.3% |
2010 | 27% | +0.1% |
2009 | 26.9% | +0.1% |
2008 | 26.8% | +0.3% |
2007 | 26.5% | +0.7% |
2006 | 25.8% | 0% |
2005 | 25.8% | +0.4% |
2004 | 25.4% | +0.5% |
2003 | 24.9% | +0.4% |
2002 | 24.5% | +0.8% |
2001 | 23.7% | +0.9% |
2000 | 22.8% |